Abstract

Losartan Potassium 2.5-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: May/Jun 2007 - Pain Management

Page(s): 248

Download in electronic PDF format for $75

Abstract

A formulation for preparing Losartan Potassium 2.5-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
May/Jun 2007 Pg. 248	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 326	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 232	Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2017 Pg. 147	Candesartan Cilexetil 8 mg Liquid-Filled Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 412	Valsartan 4 mg/mL in Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 269	Valsartan 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 1999 Pg. 415-420	Physical Compatibility of Calcium Acetate and Potassium Phosphates in Parenteral Nutrition Solutions Containing Aminosyn II Author(s): Zhang Yanping, Xu Quanyun, Trissel Lawrence A, Baker Mary B
Nov/Dec 2004 Pg. 462-465	Basics of Compounding for Cough Author(s): Allen Loyd V Jr
Jan/Feb 2003 Pg. 61	Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 237	Valsartan 16-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 139	Valsartan 4 mg/mL in Syrup NF Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 288-292	Basics of Compounding for Iontophoresis, Part II Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 323-324	Compatibility and Stability of Potassium Chloride and Magnesium Sulfate in 0.9% Sodium Chloride Injection and 5% Dextrose Injection Solutions Author(s): Quay Irene, Tan Edward
Jan/Feb 2000 Pg. 26-27	Book Review: The NMDA Receptor Author(s): Jones Marty
Sep/Oct 2005 Pg. 339-346	Dextromethorphan, an NMDA receptor antagonist, as a Treatment for Pain Author(s): Mishkan Emilyn S
May/Jun 2022 Pg. 234	Candesartan Cilexitil 1 mg/mL Syrup Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 302	Lisinopril 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 278-286	Compounded Pain Formulations: What is the Evidence? Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso